Company intelligence / Profile preview

Endpoint Health

California, United Statesendpointhealth.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Endpoint Health is developing precision therapies for immune-mediated diseases by combining data science, therapeutics, and therapy-guiding tests to understand patient biology and likely treatment responses

Therapeutic areas: Immunology
Modalities: Targeted therapeutics
Industry: Biotech

Drug pipeline

3 assets

EP006

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

Biocartis mentioned as having some relationship

Beyond the preview

Go deeper on Endpoint Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endpoint Health.

Explore the full profile